Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.29
-0.37 (-1.98%)
At close: Mar 18, 2026, 4:00 PM EDT
18.00
-0.29 (-1.59%)
Pre-market: Mar 19, 2026, 8:04 AM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.02 billion as of March 19, 2026. Its market cap has increased by 124.41% in one year.
Market Cap
3.02B
Enterprise Value
2.08B
1-Year Change
124.41%
Ranking
Category
Stock Price
$18.29
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.02B, an increase of 281.64%. That is a compound annual growth rate of 27.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 3.02B | -6.28% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 3.37B |
| Edgewise Therapeutics | 3.18B |
| Denali Therapeutics | 3.18B |
| IDEAYA Biosciences | 2.93B |
| Tarsus Pharmaceuticals | 2.90B |
| Telix Pharmaceuticals | 2.85B |
| Viridian Therapeutics | 2.83B |
| Catalyst Pharmaceuticals | 2.79B |